{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:28:41Z","timestamp":1790425721883,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T00:00:00Z","timestamp":1624838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T00:00:00Z","timestamp":1624838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurochir"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s00701-021-04911-2","type":"journal-article","created":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T06:03:10Z","timestamp":1624860190000},"page":"3143-3154","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["A clinicoradiological analysis of silent corticotroph adenomas after the introduction of pituitary-specific transcription factors"],"prefix":"10.1007","volume":"163","author":[{"given":"Abhijit","family":"Goyal-Honavar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sauradeep","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. S.","family":"Asha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Balakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshad","family":"Vanjare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geeta","family":"Chacko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari G.","family":"Chacko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,28]]},"reference":[{"key":"4911_CR1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1080\/02688690500081230","volume":"19","author":"SE Baldeweg","year":"2005","unstructured":"Baldeweg SE, Pollock JR, Powell M, Ahlquist J (2005) A spectrum of behaviour in silent corticotroph pituitary adenomas. Br J Neurosurg 19:38\u201342. https:\/\/doi.org\/10.1080\/02688690500081230","journal-title":"Br J Neurosurg"},{"key":"4911_CR2","doi-asserted-by":"publisher","first-page":"e241","DOI":"10.1016\/j.wneu.2018.08.043","volume":"120","author":"RL Batista","year":"2018","unstructured":"Batista RL, Trarbach EB, Marques MD et al (2018) Nonfunctioning Pituitary Adenoma Recurrence and Its Relationship with Sex, Size, and Hormonal Immunohistochemical Profile. World Neurosurg 120:e241\u2013e246. https:\/\/doi.org\/10.1016\/j.wneu.2018.08.043","journal-title":"World Neurosurg"},{"key":"4911_CR3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1046\/j.1365-2265.2003.01674.x","volume":"58","author":"KJ Bradley","year":"2003","unstructured":"Bradley KJ, Wass JAH, Turner HE (2003) Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumors but do not recur more frequently. Clin Endocrinol (Oxf) 58:59\u201364. https:\/\/doi.org\/10.1046\/j.1365-2265.2003.01674.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"4911_CR4","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/cen.12443","volume":"81","author":"L Cazabat","year":"2014","unstructured":"Cazabat L, Dupuy M, Boulin A et al (2014) Silent, but not unseen: multimicrocystic aspect on T2-weighted MRI in silent corticotroph adenomas. Clin Endocrinol (Oxf) 81:566\u2013572. https:\/\/doi.org\/10.1111\/cen.12443","journal-title":"Clin Endocrinol (Oxf)"},{"key":"4911_CR5","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s11102-017-0809-7","volume":"20","author":"AF Cheres","year":"2017","unstructured":"Cheres AF, ElAsmar N, Rajpal A et al (2017) Perioperative hypothalamic pituitary adrenal function in patients with silent corticotroph adenomas. Pituitary 20:471\u2013476. https:\/\/doi.org\/10.1007\/s11102-017-0809-7","journal-title":"Pituitary"},{"key":"4911_CR6","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/j.1365-2265.2009.03673.x","volume":"72","author":"HY Cho","year":"2010","unstructured":"Cho HY, Cho SW, Kim SW et al (2010) Silent corticotroph adenomas have unique recurrence characteristics compared with other nonfunctioning pituitary adenomas. Clin Endocrinol (Oxf) 72:648\u2013653. https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03673.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"4911_CR7","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1210\/jc.2018-00688","volume":"104","author":"J Drummond","year":"2019","unstructured":"Drummond J, Roncaroli F, Grossman AB, Korbonits M (2019) Clinical and Pathological Aspects of Silent Pituitary Adenomas. J Clin Endocrinol Metab 104:2473\u20132489. https:\/\/doi.org\/10.1210\/jc.2018-00688","journal-title":"J Clin Endocrinol Metab"},{"key":"4911_CR8","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01956","author":"A Fountas","year":"2018","unstructured":"Fountas A, Lavrentaki A, Subramanian A et al (2018) Recurrence in silent corticotroph adenomas after primary treatment: A systematic review and meta-analysis. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jc.2018-01956","journal-title":"J Clin Endocrinol Metab"},{"key":"4911_CR9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s00401-005-1101-x","volume":"111","author":"AB Grossman","year":"2006","unstructured":"Grossman AB (2006) The 2004 World health organization classification of pituitary tumors: is it clinically helpful? Acta Neuropathol (Berl) 111:76\u201377. https:\/\/doi.org\/10.1007\/s00401-005-1101-x","journal-title":"Acta Neuropathol (Berl)"},{"key":"4911_CR10","first-page":"320","volume":"61","author":"A Gundgurthi","year":"2013","unstructured":"Gundgurthi A, Garg MK, Dutta MK, Pakhetra R (2013) Intramuscular ACTH stimulation test for assessment of adrenal function. J Assoc Physicians India 61:320\u2013324","journal-title":"J Assoc Physicians India"},{"key":"4911_CR11","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1152\/physrev.00024.2017","volume":"98","author":"E Harno","year":"2018","unstructured":"Harno E, Gali Ramamoorthy T, Coll AP, White A (2018) POMC: The Physiological Power of Hormone Processing. Physiol Rev 98:2381\u20132430. https:\/\/doi.org\/10.1152\/physrev.00024.2017","journal-title":"Physiol Rev"},{"key":"4911_CR12","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1227\/NEU.0b013e318257c1f0","volume":"71","author":"AG Ioachimescu","year":"2012","unstructured":"Ioachimescu AG, Eiland L, Chhabra VS et al (2012) Silent corticotroph adenomas: Emory University cohort and comparison with ACTH-negative nonfunctioning pituitary adenomas. Neurosurgery 71:296\u2013303. https:\/\/doi.org\/10.1227\/NEU.0b013e318257c1f0","journal-title":"Neurosurgery"},{"key":"4911_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1227\/01.neu.0000429858.96652.1e","volume":"73","author":"A Jahangiri","year":"2013","unstructured":"Jahangiri A, Wagner JR, Pekmezci M et al (2013) A Comprehensive Long-term Retrospective Analysis of Silent Corticotrophic Adenomas vs Hormone-Negative Adenomas. Neurosurgery 73:8\u201318. https:\/\/doi.org\/10.1227\/01.neu.0000429858.96652.1e","journal-title":"Neurosurgery"},{"key":"4911_CR14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/cen.14133","volume":"92","author":"L Kasuki","year":"2020","unstructured":"Kasuki L, Antunes X, Coelho MCA et al (2020) Accuracy of microcystic aspect on T2-weighted MRI for the diagnosis of silent corticotroph adenomas. Clin Endocrinol (Oxf) 92:145\u2013149. https:\/\/doi.org\/10.1111\/cen.14133","journal-title":"Clin Endocrinol (Oxf)"},{"key":"4911_CR15","doi-asserted-by":"publisher","first-page":"e464","DOI":"10.1016\/j.wneu.2018.04.070","volume":"115","author":"D Kim","year":"2018","unstructured":"Kim D, Ku CR, Park SH et al (2018) Clinical Parameters to Distinguish Silent Corticotroph Adenomas from Other Nonfunctioning Pituitary Adenomas. World Neurosurg 115:e464\u2013e471. https:\/\/doi.org\/10.1016\/j.wneu.2018.04.070","journal-title":"World Neurosurg"},{"key":"4911_CR16","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3340\/jkns.2018.0027","volume":"62","author":"J Kim","year":"2019","unstructured":"Kim J, Yoon SJ, Moon JH et al (2019) Clinical Significance of Radical Surgery in the Treatment of Silent Corticotroph Adenoma. J Korean Neurosurg Soc 62:114\u2013122. https:\/\/doi.org\/10.3340\/jkns.2018.0027","journal-title":"J Korean Neurosurg Soc"},{"key":"4911_CR17","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000192449","volume":"71","author":"M Korbonits","year":"2009","unstructured":"Korbonits M, Carlsen E (2009) Recent Clinical and Pathophysiological Advances in Non-Functioning Pituitary Adenomas. Horm Res Paediatr 71:123\u2013130. https:\/\/doi.org\/10.1159\/000192449","journal-title":"Horm Res Paediatr"},{"key":"4911_CR18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11102-017-0844-4","volume":"21","author":"F Langlois","year":"2018","unstructured":"Langlois F, Lim DST, Yedinak CG et al (2018) Predictors of silent corticotroph adenoma recurrence; a large retrospective single center study and systematic literature review. Pituitary 21:32\u201340. https:\/\/doi.org\/10.1007\/s11102-017-0844-4","journal-title":"Pituitary"},{"key":"4911_CR19","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/PCR.0000000000000180","volume":"22","author":"RY Osamura","year":"2017","unstructured":"Osamura RY (2017) Pathology of Pituitary Tumors Update: With World Health Organization new Classification 2017. AJSP Rev Rep 22:189\u2013195. https:\/\/doi.org\/10.1097\/PCR.0000000000000180","journal-title":"AJSP Rev Rep"},{"key":"4911_CR20","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s11102-019-00982-8","volume":"22","author":"AL Pappy","year":"2019","unstructured":"Pappy AL, Savinkina A, Bicknese C et al (2019) Predictive modeling for pituitary adenomas: single center experience in 501 consecutive patients. Pituitary 22:520\u2013531. https:\/\/doi.org\/10.1007\/s11102-019-00982-8","journal-title":"Pituitary"},{"key":"4911_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1530\/EJE-10-0076","volume":"163","author":"G Raverot","year":"2010","unstructured":"Raverot G, Wierinckx A, Jouanneau E et al (2010) Clinical, hormonal and molecular characterization of pituitary ACTH adenomas without (silent corticotroph adenomas) and with Cushing\u2019s disease. Eur J Endocrinol 163:35\u201343. https:\/\/doi.org\/10.1530\/EJE-10-0076","journal-title":"Eur J Endocrinol"},{"key":"4911_CR22","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s12020-016-1028-0","volume":"56","author":"A Righi","year":"2017","unstructured":"Righi A, Faustini-Fustini M, Morandi L et al (2017) The changing faces of corticotroph cell adenomas: the role of prohormone convertase 1\/3. Endocrine 56:286\u2013297. https:\/\/doi.org\/10.1007\/s12020-016-1028-0","journal-title":"Endocrine"},{"key":"4911_CR23","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1007\/s00701-017-3223-z","volume":"159","author":"S Sarkar","year":"2017","unstructured":"Sarkar S, Philip VJ, Cherukuri SK et al (2017) Implications of the World Health Organization definition of atypia on surgically treated functional and non-functional pituitary adenomas. Acta Neurochir (Wien) 159:2179\u20132186. https:\/\/doi.org\/10.1007\/s00701-017-3223-z","journal-title":"Acta Neurochir (Wien)"},{"key":"4911_CR24","doi-asserted-by":"publisher","first-page":"E539","DOI":"10.1227\/NEU.0000000000001385","volume":"79","author":"J Sheehan","year":"2016","unstructured":"Sheehan J, Lee C-C, Bodach ME et al (2016) Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline for the Management of Patients With Residual or Recurrent Nonfunctioning Pituitary Adenomas. Neurosurgery 79:E539\u2013E540. https:\/\/doi.org\/10.1227\/NEU.0000000000001385","journal-title":"Neurosurgery"},{"key":"4911_CR25","doi-asserted-by":"publisher","first-page":"E226","DOI":"10.1093\/neuros\/nyy479","volume":"85","author":"K Sterl","year":"2019","unstructured":"Sterl K, Thompson B, Goss CW et al (2019) Withholding Perioperative Steroids in Patients Undergoing Transsphenoidal Resection for Pituitary Disease: Randomized Prospective Clinical Trial to Assess Safety. Neurosurgery 85:E226\u2013E232. https:\/\/doi.org\/10.1093\/neuros\/nyy479","journal-title":"Neurosurgery"},{"key":"4911_CR26","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3171\/2008.4.17517","volume":"111","author":"G Widhalm","year":"2009","unstructured":"Widhalm G, Wolfsberger S, Preusser M et al (2009) Residual nonfunctioning pituitary adenomas: prognostic value of MIB-1 labeling index for tumor progression: Clinical article. J Neurosurg 111:563\u2013571. https:\/\/doi.org\/10.3171\/2008.4.17517","journal-title":"J Neurosurg"},{"key":"4911_CR27","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1227\/01.NEU.0000290906.53685.79","volume":"61","author":"S Yamada","year":"2007","unstructured":"Yamada S, Ohyama K, Taguchi M et al (2007) A study of the correlation between morphological findings and biological activities in clinically nonfunctioning pituitary adenomas. Neurosurgery 61:580\u2013585. discussion 584-585. https:\/\/doi.org\/10.1227\/01.NEU.0000290906.53685.79","journal-title":"Neurosurgery"},{"key":"4911_CR28","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/cen.13888","volume":"90","author":"BB Yeap","year":"2019","unstructured":"Yeap BB, Wu FCW (2019) Clinical practice update on testosterone therapy for male hypogonadism: Contrasting perspectives to optimize care. Clin Endocrinol (Oxf) 90:56\u201365. https:\/\/doi.org\/10.1111\/cen.13888","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Acta Neurochirurgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-021-04911-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00701-021-04911-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-021-04911-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T17:42:02Z","timestamp":1634406122000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00701-021-04911-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,28]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["4911"],"URL":"https:\/\/doi.org\/10.1007\/s00701-021-04911-2","relation":{},"ISSN":["0001-6268","0942-0940"],"issn-type":[{"value":"0001-6268","type":"print"},{"value":"0942-0940","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,28]]},"assertion":[{"value":"3 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was commenced following approval from the Christian Medical College Institutional Review Board (IRB Minute No. 12280).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"As this manuscript is based on retrospectively collected data without revealing the identity of subjects, patient consent was not obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Sources of support"}},{"value":"The authors report no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}